<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03988504</url>
  </required_header>
  <id_info>
    <org_study_id>RBK 358</org_study_id>
    <nct_id>NCT03988504</nct_id>
  </id_info>
  <brief_title>Impact of Predictive Genetic Testing</brief_title>
  <official_title>Impact of Predictive Genetic Testing on Quality of Life and Health-related Behaviour</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Robert Bosch Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Robert Bosch Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Analysing Impact of preemptive genetic testing on quality of life, physical activity and
      eating behavior at baseline and 3 months after testing.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2016</start_date>
  <completion_date type="Actual">January 31, 2018</completion_date>
  <primary_completion_date type="Actual">January 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of Life assessed by the SF-36 questionnaire [followed by its scale information in the Description]</measure>
    <time_frame>3 months</time_frame>
    <description>Short form (36) (SF-36) questionnaire evaluates health related quality of life (Scale 0-100)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Physical activity assessed by the IPAQ questionnaire [followed by its scale information in the Description]</measure>
    <time_frame>3 months</time_frame>
    <description>International Physical Activity Questionnaire (IPAQ) evaluates physical activity in MET(metabolic equivalent)/min/week</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Eating behavior assessed by the modified LEI questionnaire [followed by its scale information in the Description]</measure>
    <time_frame>3 months</time_frame>
    <description>The modified Luzerner Ernaehrungs Index (LEI) questionnaire evaluates eating behavior at lunch (Scale 1-4 per item; 1=never; 4=daily)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with check up and genetic testing: Likert scale (1-10)</measure>
    <time_frame>3 months</time_frame>
    <description>Likert scale (1-10)</description>
  </secondary_outcome>
  <enrollment type="Actual">241</enrollment>
  <condition>Genetic Testing</condition>
  <condition>Quality of Life</condition>
  <condition>Physical Activity</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Routine check up including genetic testing</intervention_name>
    <description>Intervention is a routine check up including preemptive genetic testing</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy subjects with request for health check up at Robert-Bosch-Hospital
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age â‰¥18 years

          -  informed consent for genetic testing

          -  informed consent for study participation

        Exclusion Criteria:

          -  Age &lt;18 years

          -  renal replacement dependency

          -  pregnancy

          -  active cancer disease

          -  no informed consent for genetic testing or study participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 12, 2019</study_first_submitted>
  <study_first_submitted_qc>June 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 17, 2019</study_first_posted>
  <last_update_submitted>June 14, 2019</last_update_submitted>
  <last_update_submitted_qc>June 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Robert Bosch Medical Center</investigator_affiliation>
    <investigator_full_name>Prof. Dr. med. Mark Dominik Alscher</investigator_full_name>
    <investigator_title>Medical Director, Managing Director</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>On request</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

